Cargando…
Observed versus expected morbidity and mortality in patients undergoing mitral valve repair
OBJECTIVES: Mitral valve repair (MVP) is the gold standard treatment for degenerative mitral regurgitation. With the expansion of transcatheter technologies, this study compares the outcome of MVP in low-risk and non-low-risk patients to serve as a benchmark. METHODS: This retrospective, single-inst...
Autores principales: | Newell, Paige, Tartarini, Richard, Hirji, Sameer, Harloff, Morgan, McGurk, Siobhan, Cherkasky, Olena, Kaneko, Tsuyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553224/ https://www.ncbi.nlm.nih.gov/pubmed/36205629 http://dx.doi.org/10.1093/icvts/ivac241 |
Ejemplares similares
-
All-cause procedural readmissions following transcatheter aortic valve replacement
por: Newell, Paige, et al.
Publicado: (2023) -
Early outcomes of transatrial mitral valve replacement in severe mitral annular calcification
por: Kawano, Yuji, et al.
Publicado: (2021) -
Hybrid valve-in-valve mitral valve replacement
por: Harloff, Morgan T., et al.
Publicado: (2020) -
Transcatheter Compared With Surgical Aortic Valve Replacement in Patients With Previous Chest-Directed Radiation Therapy
por: Yazdchi, Farhang, et al.
Publicado: (2021) -
Minimally invasive mitral valve surgery after failed transcatheter mitral valve repair in an intermediate-risk cohort
por: Akansel, Serdar, et al.
Publicado: (2022)